On/Go is manufactured in the United States for Intrivo, a US-based health-tech leader harnessing the power of AI to help control COVID-19 while preparing the world to tackle future health challenges and helping everyone live happier, healthier, safer lives.
In the past year, Intrivo has delivered tens of millions of FDA-authorized COVID-19 tests worldwide, achieved multiple FDA and other authorizations across a variety of markets, while leveraging its superior patent-pending technology. While the company is currently focused on the global COVID-19 pandemic, it will expand its solutions to make healthcare more accessible and affordable for both consumers and enterprises alike.
Intrivo launches On/Go™, an FDA-authorized at-home rapid COVID-19 self-test, delivering 95% accuracy in just 10 minutes.
In the past, some of the press and social commentary about rapid antigen tests has been negative. This mainly reflects the...
The On/Go™ COVID-19 Antigen Self-Test is an over-the-counter, self-performed rapid test for the detection of SARS-CoV-2. This test is authorized for non-prescription home use by individuals aged 14 years or older or adult collected from individuals aged 2 years or older. The test is made easy with the On/Go companion app, which provides clear, step-by-step instructions for specimen collection and result interpretation.